Also trades as: NEU.AX (ASX) · $vol 8M
NURPF OTC
Neuren Pharmaceuticals Limited
1W: +2.4%
1M: -12.1%
3M: +19.0%
YTD: +10.6%
1Y: +19.0%
3Y: +62.8%
5Y: +1313.9%
$14.28
+0.34 (+2.42%)
Weekly Expected Move ±6.0%
$13
$13
$14
$15
$16
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$343M
-16.3% ▼
5Y CAGR: +68.9%
Total Liabilities
$4M
-90.4% ▼
5Y CAGR: +42.4%
Shareholders Equity
$338M
-7.0% ▼
5Y CAGR: +69.5%
Cash & Investments
$296M
+33.2% ▲
5Y CAGR: +65.0%
Total Debt
$0
+0.0% ▲
Net Debt
-$4M
-34.0% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $37M | $40M | $17M | $3M | $4M |
| Short-Term Investments | $0 | $0 | $211M | $219M | $292M |
| Cash & ST Investments | $37M | $40M | $229M | $222M | $296M |
| Net Receivables | $1M | $1M | $14M | $158M | $27M |
| Inventory | $0 | $0 | $0 | $15M | $0 |
| Other Current Assets | $0 | $0 | $0 | $4M | $0 |
| Total Current Assets | $40M | $43M | $247M | $399M | $332M |
| Property, Plant & Equip. | $12K | $21K | $43K | $31K | $45K |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Assets | $12K | $21K | $814K | $10M | $11M |
| Total Assets | $40M | $43M | $248M | $410M | $343M |
| — Liabilities — | |||||
| Accounts Payable | $245K | $258K | $675K | $1M | $877K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $967K | $4M | $41M | $3M |
| Total Current Liabilities | $803K | $2M | $43M | $46M | $4M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $41K | $68K |
| Total Non-Current Liabilities | $0 | $0 | $0 | $41K | $68K |
| Total Liabilities | $803K | $2M | $43M | $46M | $4M |
| — Equity — | |||||
| Common Stock | $168M | $168M | $173M | $165M | $135M |
| Retained Earnings | -$119M | -$119M | $38M | $180M | $211M |
| Accumulated OCI | -$9M | -$7M | -$6M | $18M | -$7M |
| Total Stockholders Equity | $39M | $42M | $205M | $364M | $338M |
| Total Liabilities & Equity | $40M | $43M | $248M | $410M | $343M |
| — Key Metrics — | |||||
| Total Debt | $0 | $0 | $0 | $0 | $0 |
| Net Debt | -$37M | -$40M | -$17M | -$3M | -$4M |
| Total Investments | $0 | $0 | $211M | $219M | $292M |